RSRudi Supriyadi

Rudi Supriyadi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rudi Supriyadi has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Ria Bandiara

    Department of Internal Medicine , Faculty of Medicine , Hasan Sadikin General Hospital , Padjadjaran University , Bandung , Indonesia , unpad.ac.id

    2 shared publications
  • Afiatin Makmun

    Affiliations Department of Internal Medicine, Faculty of Medicine Universitas Padjadjaran, Dr. Hasan Sadikin General Hospital, Bandung, West Java, Indonesia, Division of Nephrology and Hypertension, Faculty of Medicine, Universitas Padjadjaran, Dr. Hasan Sadikin Bandung General Hospital, West Java, Indonesia

    1 shared publication
  • Agnes Rengga Indrati

    Department of Clinical Pathology, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia

    1 shared publication
  • Bachti Alisjahbana

    Research Center for Care and Control of Infectious Diseases (RC3ID), Universitas Padjadjaran, Bandung, Indonesia

    1 shared publication
  • Fahrizal Yanuar Rahmattulloh

    1 shared publication
  • Fauliza Rakhima

    Division of Nephrology and Hypertension, Department of Internal Medicine, Faculty of Medicine Universitas Padjadjaran – Hasan Sadikin Hospital, Bandung, Indonesia

    1 shared publication

Latest Publications

  • Open Access

    A Systematic Review and Meta‐Analysis of the Association Between Obesity and Albuminuria in Asian People

    by Maria Riastuti Iryaningrum, Louis Fabio Jonathan Jusni, Rivaldi Ruby, Ria Bandiara, Yunia Sribudiani, Nanny Natalia Mulyani Soetedjo, Rudi Supriyadi

    Obesity‐related renal dysfunction is largely attributed to hemodynamic alterations and insulin resistance. Among individuals with overweight or obesity, albuminuria has been shown to be independently and inversely associated with circulating adiponectin levels in the absence of diabetes. Accordingly, this study aimed to evaluate and quantify the independent association between obesity and the risk of kidney disease, as assessed by the presence of albuminuria in the Asian Population. This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines. A comprehensive and systematic search strategy was applied across multiple electronic databases, including PubMed, ProQuest, Taylor & Francis, and Wiley, to identify relevant studies meeting the eligibility criteria. Data synthesis and statistical analyses were carried out using Review Manager (RevMan) software Version 5.4, and the methodological rigor of the included studies was independently assessed using the Newcastle–Ottawa Scale (NOS). The pooled analysis demonstrated that obesity was significantly associated with albuminuria in the general population as well as in sex‐specific subgroups. Specifically, the odds of albuminuria were higher among individuals with obesity in the overall population (OR = 1.76; 95% CI: 1.09–2.83; p = 0.02, I 2 = 78%), in men (OR = 1.34; 95% CI: 1.05–1.71; p = 0.02, I 2 = 63%), and in women (OR = 1.16; 95% CI: 1.05–1.28; p = 0.004, I 2 = 19%). Obesity was associated with albuminuria in Asian Populations.

  • Open Access

    Inflammatory Marker Trajectories in Pulmonary COVID-19: An Analysis of IL-6, hsCRP, and IFN-γ

    by Prayudi Santoso, Fahrizal Yanuar Rahmattulloh, Sasfia Candrianita, Rudi Supriyadi, Agnes Rengga Indrati, Keri Lestari, Haig Babikian

    Introduction: Multiple inflammatory markers, including high sensitivity C-reactive protein (hsCRP), procalcitonin, interleukin-6 (IL-6), D-dimer, lactate dehydrogenase (LDH), and ferritin, have demonstrated significant sensitivity as predictors of COVID-19 severity. However, there is a paucity of research investigating the association of IL-6, CRP, and interferon-gamma (IFN-γ) with day of illness in confirmed mild and moderate pulmonary COVID-19 cases in Indonesia. Methods: This retrospective analytic study utilised secondary data extracted from the medical records. The study was conducted over a nine-month period, from December 2020 to October 2021, and included a total of 80 subjects. These subjects were categorised into 60 mild and 20 moderate COVID-19 cases. Results: Analysis revealed a statistically significant difference in median IL-6 levels, with moderate cases exhibiting higher levels than mild cases (4.50 pg/mL vs. 2.87 pg/mL, difference = 1.63 pg/mL; p=0.008). Similarly, median hsCRP levels were significantly elevated in moderate cases compared to mild cases (3.85 mg/L vs. 0.90 mg/L, difference = 2.95 mg/L; p=0.001). Conversely, IFN-γ levels did not demonstrate a significant difference between moderate and mild cases (0.23 pg/mL vs. 0.28 pg/mL; p=0.907). Regarding temporal trends, IL-6 levels tended to increase until the fourth day of illness before declining on the fifth day. hsCRP levels were elevated on the first and fourth days but decreased by the fifth day, while IFN-γ concentrations peaked on the first and third days. Conclusion: This study demonstrates a significant elevation in IL-6 and hsCRP levels in patients with confirmed moderate COVID-19, compared to those with mild disease. However, no significant difference was observed in IFN-γ levels between these two groups. Peak levels of IL-6 and hsCRP were recorded on day 1 and day 4 of illness, respectively.

  • Open Access

    Stem cell intervention and eGFR dynamics in chronic kidney disease, tracking renal function improvement: A systematic review and meta-analysis

    by Kevin Yonatan Budiman, Lukman Pura, Afiatin Afiatin, Rudi Supriyadi

    Chronic kidney disease (CKD) poses a significant global health burden with limited therapeutic options to reverse renal function decline. This systematic review and meta-analysis evaluated the effectiveness of mesenchymal stem cell (MSC) interventions in CKD patients by analyzing changes in estimated glomerular filtration rate (eGFR). An electronic search of PubMed, Scopus, EBSCOhost, and ScienceDirect was performed for all articles about MSC therapy for CKD with eGFR as the primary outcome, from January 2015 to March 2025. Data were pooled for analysis with Stata. A total of 13 study groups from ten eligible studies were included, encompassing both controlled and single-arm trials with various MSC sources and dosages. Meta-analysis of controlled studies, which notably all shared the same etiology of diabetic kidney disease, demonstrated a significant improvement in eGFR following MSC therapy compared to controls (mean difference: 10.08 mL/min/1.73 m2; 95% CI: 2.92–17.24; p=0.01), indicating a potential benefit of MSC in enhancing renal function. However, pooled single-arm analyses revealed a non-significant overall eGFR change (mean difference: 1.14 mL/min/1.73 m2; p=0.62) with considerable heterogeneity across studies. MSC therapy shows promise for improving renal function in CKD, particularly in controlled settings with diabetic kidney disease, but further large-scale, standardized randomized trials are necessary to confirm its clinical utility and optimize treatment protocols.

  • Open Access

    Prevalence and Factors Associated with Sarcopenia in Chronic Kidney Disease Patients Undergoing Dialysis: A Single Center, Cross-sectional Study

    by Fauliza Rakhima, Ria Bandiara, Rudi Supriyadi, Lazuardhi Dwipa

    Background: Sarcopenia is associated with worse outcomes in stage 5 Chronic Kidney Disease on dialysis (CKD 5D) patients, influenced by various diagnostic criteria and patient characteristics. Nonetheless, the factors contributing to sarcopenia in CKD 5D remain underexplored. Objective: To investigate the prevalence and factors associated with sarcopenia in the CKD 5D population. Methods: An observational cross-sectional study was conducted on 132 CKD 5D patients (≥18 years old, dialysis ≥ 3 months) at Hasan Sadikin Hospital from July to August 2024. Descriptive statistics, bivariate analysis, and logistic regression were utilized to determine the prevalence of sarcopenia and its association with the Simplify Creatinine Index (SCI), physical activity, nutritional status, phosphate, and calcium serum levels. Hand Grip Strength (HGS) assessed muscle strength, Bioelectrical Impedance Spectroscopy (BIS) measured muscle mass, the 6-meter walk test evaluated physical performance, and the Asian Working Group for Sarcopenia (AWGS) 2019 criteria were employed for diagnosing sarcopenia. Results: Sarcopenia prevalence was 15.9%. Bivariate analysis revealed significant correlations with underweight (p=0.014), malnutrition (p=0.041), phosphate serum level (p=0.047), and calcium serum level (p=0.043). Logistic regression indicated that higher serum levels of calcium and phosphate and healthy nutritional status, served as protective factors against sarcopenia, with odds ratios of 0.677 (OR 0.677; CI 95% 0.493-0.93 and OR 0.313; CI 95% 0.130-0.755). Conclusion: Sarcopenia prevalence was 15.9%. Phosphate and calcium serum levels, underweight, and malnutrition were significantly correlated with sarcopenia. Higher serum phosphate and calcium levels, higher body weight, and good nutrition status were protective factors against sarcopenia in CKD 5D patients.


  • Open Access

    25. PRO-INFLAMMATORY MARKERS IN COVID-19 PATIENTS WITH HYPERTENSION

    by Rizky Andhika, Rudi Supriyadi, Bachti Alisjahbana

    Background: : Hypertension is associated with poor outcome in patients with Coronavirus Disease-2019 (COVID-19). Several pro-inflammatory markers, such as Absolute Lymphocyte Count (ALC), Neutrophil-to-Lymphocyte Ratio (NLCR), Monocyte-to-Lymphocyte Ratio (MLCR), C-Reactive Protein (CRP), Procalcitonin (PCT), and Ferritin are associated with poor outcome in COVID-19. Pro-inflammatory markers in COVID-19 patients with hypertension is rarely described. Objective: : We aimed to explore several pro-inflammatory markers in COVID-19 patients with hypertension. Methods: We retrospectively analysed confirmed COVID-19 patients between March 1 and August 31, 2020 from Hasan Sadikin General Hospital Bandung. Data were obtained from patient's medical records. Patients with history of hypertension before admission were included in hypertension group. Patients with systolic blood pressure (BP) above 140 mmHg and/or diastolic BP above 90 mmHg on admission, were considered as uncontrolled hypertension. The analysis of data correlation was done using the Pearson correlation, alternative Rank Spearman correlation for non-normal distribution. Results: : We found 140 patients, in which 40 patients were included in hypertension group. NLCR (5.29 vs. 2.92, p = 0.002), MLCR (0.47 vs 0.31, p = 0.001), and CRP (5.62 vs 0.87, p = 0.004) were significantly higher in COVID-19 patients with hypertension. Meanwhile, ALC was found to be lower (1233.9 vs. 1533.9, p = 0.009). PCT (0.05 vs. 0.02, p = 0.079) and ferritin (329.3 vs 224.1, p = 0.073) were higher, but not statistically significant. There was no difference of NLCR, MLCR, CRP, ALC, PCT, and ferritin level between uncontrolled and controlled hypertension group. Conclusion: : COVID-19 patients with hypertension have higher pro-inflammatory markers.

  • Open Access

    Increase Serum Tumor Necrosis Factor Alpha decreased Serum Cholesterol Level, but not Albumin, in Hemodialysis Patients with Non-Fibrotic Hepatitis C Infection

    by Rudi Supriyadi, Nenny Agustanti, Marcella Adisuhanto

    BACKGROUND: Hepatitis C infection could increase the morbidity and mortality of chronic kidney disease patients on hemodialysis by enhancing the inflammatory process. Tumor Necrosis Factor-alpha (TNF-a) is the main regulator of the inflammatory cascade, which could induce malnutrition and suppress cholesterol and albumin production in the liver. AIM: Therefore, this study aimed to determine the correlation between serum TNF-a level with serum albumin and cholesterol levels in chronic kidney disease patients on hemodialysis with and without hepatitis C infection. METHODS: This research was an analytical cross-sectional study. The sample of this study consisted of patients undergoing routine hemodialysis at Dr. Hasan Sadikin Hospital, Bandung, in February 2020. The sample selection was using a random sampling method and analyzed with the Spearman rank correlation test. RESULTS: One hundred nineteen patients were divided into two groups, with hepatitis C infection (n=53) and without hepatitis C infection (n=66). The median value of serum TNF-α _was higher in the hepatitis C infection group compared to the group without hepatitis c infection (31.86 pg/ml vs 11.71 pg/ml, p <0.001). There was a correlation between serum TNF-α _and cholesterol in the hepatitis C infection (r = -0.246; p = 0.039) and without hepatitis c infection group (r = -0.256; p = 0.022). After adjusting with the duration of hemodialysis, this association was found to be significant in patients without Hepatitis C infection (p = 0.02) and borderline significant in patients with Hepatitis C infection (p = 0.09). There was no correlation between TNF-α _with albumin in both hepatitis C infection group (r = 0.082; p = 0.281) and without hepatitis C infection (r = -0.168; p = 0.094). CONCLUSION: Serum TNF-α _negatively correlates with cholesterol levels in chronic kidney disease patients on hemodialysis with and without hepatitis C infection. However, there was no correlation between TNF-α _and albumin level in both groups.